India's Serum Institute Gets DGCI Nod To Manufacture Covid Vaccine Against Omicron Variant For Test, Analysis
The cumulative COVID-19 vaccine doses administered in the country crossed 170 crore landmark on Monday. Development of this vaccine shall be another example of vaccine production strength of our country in line with the clarion call of our prime minister 'Making in India for the World'.